More firms suffer from lackluster sales in first quarter

Korea’s drug companies saw their first-quarter revenues drop compared to the last quarter due to the policy, geared toward eliminating the illegal kickbacks from drug firms to doctors and pharmacists.

According to the data released by the Financial Supervisory Service on Monday, nine of the 17 drug firms including Green Cross Corp., Ildong Pharm and LG Life Sciences chalked up losses in turn...